Canadian Consensus Guidelines for the Optimal Use of Etravirine in the Treatment of HIV‐Infected Adults
Author(s) -
Marianne Harris,
Jonathan B. Angel,
Jean-Guy Baril,
Anita Rachlis,
Benoît Trottier
Publication year - 2008
Publication title -
canadian journal of infectious diseases and medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.634
H-Index - 38
eISSN - 1918-1493
pISSN - 1712-9532
DOI - 10.1155/2009/658125
Subject(s) - etravirine , human immunodeficiency virus (hiv) , virology , medicine , antiretroviral therapy , viral load
A group of five Canadian physicians with significant experience in HIV management was convened. Their goal was to develop guidance specifically for Canadian HIV-treating physicians on the appropriate use of etravirine (TMC125, Intelence, Tibotec BVBA, Belgium) in adult HIV-infected patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom